AMA
Wojtulewicz M, Rękas M, Wierzbowska J. Subconjuctival application of 5-fluorouracil (5-FU) following surgical treatment of glaucoma with deep sclerectomy – indications, complications and initial evaluation of efficacy. Klinika Oczna / Acta Ophthalmologica Polonica. 2005;107(2):232-235.
APA
Wojtulewicz, M., Rękas, M., & Wierzbowska, J. (2005). Subconjuctival application of 5-fluorouracil (5-FU) following surgical treatment of glaucoma with deep sclerectomy – indications, complications and initial evaluation of efficacy. Klinika Oczna / Acta Ophthalmologica Polonica, 107(2), 232-235.
Chicago
Wojtulewicz, Małgorzata, Marek Rękas, and Joanna Wierzbowska. 2005. "Subconjuctival application of 5-fluorouracil (5-FU) following surgical treatment of glaucoma with deep sclerectomy – indications, complications and initial evaluation of efficacy". Klinika Oczna / Acta Ophthalmologica Polonica 107 (2): 232-235.
Harvard
Wojtulewicz, M., Rękas, M., and Wierzbowska, J. (2005). Subconjuctival application of 5-fluorouracil (5-FU) following surgical treatment of glaucoma with deep sclerectomy – indications, complications and initial evaluation of efficacy. Klinika Oczna / Acta Ophthalmologica Polonica, 107(2), pp.232-235.
MLA
Wojtulewicz, Małgorzata et al. "Subconjuctival application of 5-fluorouracil (5-FU) following surgical treatment of glaucoma with deep sclerectomy – indications, complications and initial evaluation of efficacy." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 107, no. 2, 2005, pp. 232-235.
Vancouver
Wojtulewicz M, Rękas M, Wierzbowska J. Subconjuctival application of 5-fluorouracil (5-FU) following surgical treatment of glaucoma with deep sclerectomy – indications, complications and initial evaluation of efficacy. Klinika Oczna / Acta Ophthalmologica Polonica. 2005;107(2):232-235.
